| Subject: | FDA Taking Actions to Reduce Risk Of Overdose With Propoxyphene-Containing Products |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 8 Jul 2009 - 11:00 am |
| Audience: Pharmacists, Pain management healthcare professionals The Food and Drug Administration (FDA) is notifying healthcare professionals that it is taking several actions to reduce the risk of overdose in patients using pain medications that contain propoxyphene because of data linking propoxyphene and fatal overdoses. These actions include:Requiring manufacturers of propoxyphene-containing products to strengthen the label, including the boxed warning, emphasizing the potential for... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|